Increased expression of AML1-a and acquired chromosomal abnormalities in childhood acute lymphoblastic leukemia

Hematological Oncology

Volumn 22, Issue 3, 2004, Pages 85-90

  Gutierrez Angulo M ^a,c   Gonzalez Garcia J R ^a   Meza Espinoza, J P ^a   Picos Cardenas V J ^a   Esparza Flores, M A ^b   Lopez Guido B ^b   Rivera, Horacio ^a  

^a CENTRO DE INVESTIGACIÓN BIOMÉDICA DE OCCIDENTE   (Mexico)

^b HOSPITAL DE PEDIATRÍA   (Mexico)

^c UNIVERSITY OF GUADALAJARA   (Mexico)

Author keywords

Acquired chromosomal abnormalities; Aml1 A isoform; Gene expression

Indexed keywords

TRANSCRIPTION FACTOR RUNX1;

ACUTE LYMPHOBLASTIC LEUKEMIA; BLOOD SAMPLING; BONE MARROW; CHILDHOOD DISEASE; CHROMOSOME ABERRATION; CHROMOSOME ANALYSIS; COMPARATIVE STUDY; DISEASE ASSOCIATION; DISEASE COURSE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE EXPRESSION; HUMAN; KARYOTYPE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW;

ADOLESCENT; BONE MARROW; CHILD; CHILD, PRESCHOOL; CHROMOSOME ABERRATIONS; CHROMOSOMES, HUMAN, PAIR 21; CORE BINDING FACTOR ALPHA 2 SUBUNIT; DNA-BINDING PROTEINS; FEMALE; GENE EXPRESSION REGULATION, LEUKEMIC; HUMANS; KARYOTYPING; LEUKEMIA, LYMPHOCYTIC, ACUTE, L1; MALE; PROTO-ONCOGENE PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANSCRIPTION FACTORS;

EID: 22244488704     PISSN: 02780232     EISSN: None     Source Type: Journal    
DOI: 10.1002/hon.734     Document Type: Review

References (15)

1. Miyoshi H, Ohira M, Shimizu K, et al. Alternative splicing and genomic structure of the AML1 gene involved in acute myeloid leukemia. Nucleic Acids Res 1995; 23: 2762-2769.
2. Ghozi MC, Bernstein Y, Negreanu V, Levanon D, Groner Y. Expression of the human acute myeloid leukemia gene AML1 is regulated by two promoter regions. Proc Natl Acad Sci 1996; 93: 1935-1940.
3. Lutterbach B, Hiebert SW. Role of the transcription factor AML-1 in acute leukemia and hematopoietic differentiation. Gene 2000; 245: 223-235.
4. Tanaka T, Tanaka K, Ogawa S, et al. An acute myeloid gene, AML1, regulates hemopoietic myeloid cell differentiation and transcriptional activation antagonistically by two alternative spliced forms. EMBO J 1995; 14: 341-350.
5. Speck NA, Stacy T, Wang Q, et al. Core-binding factor: a central player in hematopoiesis and leukemia. Cancer Res 1999; 59(Suppl.): 1789-1793.
6. Okuda T, Deusern JV, Hiebert SW, Grosveld G, Downing JR. AML1, the target of multiple chromosomal translocations in human leukemia, is essential for normal fetal liver hematopoiesis. Cell 1996; 84: 321-330.
7. Perry C, Eldor A, Soreq H. Runx1/AML1 in leukemia: disrupted association with diverse protein partners. Leuk Res 2000; 26: 221-228.
8. Czepulkowski B. Basic techniques for the preparation and analysis of chromosomes from bone marrow and leukaemic blood. In Human Cytogenetics: Malignancy and Acquired Abnormalities, Rooney DE (ed.). Oxford University Press, 2001; 1-26.
9. Niini T, Kanerva J, Vettenranta K, Saarinen-Pihkala UM, Knuutila S. AML1 gene amplification: a novel finding in childhood acute lymphoblastic leukemia. Haematologica 2000; 85: 362-366.
10. Mikhail FM, Serry KA, Hatem N, et al. AML1 gene over-expression in childhood acute lymphoblastic leukemia. Leukemia 2002; 16: 658-668.
11. Penther D, Preudhomme C, Talmant P, et al. Amplification of AML1 gene is present in childhood acute lymphoblastic leukemia but not in adult, and is not associated with AML1 gene mutation. Leukemia 2002; 16: 1131-1134.
12. Michaud J, Wu F, Osato M, et al. In vitro analyses of known and novel RUNX1/AML1 mutations in dominant familial platelet disorder with predisposition to acute myelogenous leukemia: implications for mechanisms of pathogenesis. Blood 2002; 99: 1364-1372.
13. Song WJ, Sullivan MG, Legare RD, et al. Haploinsufficiency of CBFA2 causes familial thrombocytopenia with propensity to develop acute myelogenous leukaemia. Nat Genet 1999; 23: 166-175.
14. Barton K, Nucifora G. AML1 haploinsufficiency, gene dosage, and predisposition to acute leukemia. Bioessays 2000; 22: 214-218.
15. Osato M, Asou N, Abdalla E, et al. Biallelic and heterozygous point in the runt domain of the AML1/ PEBP2αB gene associated with myeloblastic leukemias. Blood 1999; 93: 1817-1824.